Six‐month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Sajatovic M, Levin J, Tatsuoka C, Micula‐Gondek W, Fuentes‐Casiano E, Bialko CS, Cassidy KA. Six‐month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disord 2012: 14: 291–300. © 2012 The Authors. Journal compilation © 2012 John Wiley & Sons A/S. Background: There are few psychosocial interventions specifically focused on improved treatment adherence in people with bipolar disorder (BD). Customized adherence enhancement (CAE) is a needs‐based, manualized approach intended to improve medication adherence in individuals with BD. This was a six‐month prospective trial of a CAE among 43 medication non‐adherent individuals with BD who were receiving treatment in a community mental health clinic (CMHC). Methods: CAE was flexibly administered in modules applied as indicated by an initial adherence vulnerabilities screening. Screening identified reasons for non‐adherence and modules were then administered using pre‐set criteria. CAE effects were evaluated at six‐week, three‐month, and six‐month follow‐up. The six‐month follow‐up was our primary time point of interest. The primary outcome was change from baseline in adherence using the Tablets Routine Questionnaire (TRQ) and pill counts. Secondary outcomes included change from baseline in BD symptoms [Hamilton Depression Rating Scale (HAM‐D), Young Mania Rating Scale (YMRS), and Brief Psychiatric Rating Scale (BPRS)]. Results: Subjects completed 86% of scheduled sessions, with only two individuals (5%) not participating in any sessions. The number of dropouts at six months was 12 (28%). Mean baseline non‐adherence by TRQ was 48% [standard error (SE) 4.8%] missed tablets within the previous week and 51% (4.1%) missed tablets within the previous month. At six‐month follow‐up, mean TRQ non‐adherence improved to 25% (6.8%) missed tablets for the previous week (p = 0.002) and 21% (5.5%) for the previous month (p < 0.001). Symptoms improved, with a change in the baseline mean (SE) BPRS of 43.6 (1.8) versus an endpoint of 36.1 (2.3) (p = 0.001), and baseline mean (SE) HAM‐D of 17.8 (1.1) versus an endpoint of 15.3 (1.6) (p = 0.044). Conclusion: CAE was associated with improvements in adherence, symptoms, and functional status. Controlled trials are needed to confirm these preliminary findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Miklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Wisniewski, S. R., Kogan, J. N., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Gyulai, L., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.419 · Cited by 537 · cited 1×
“Additionally, these interventions are characterized by high time duration and intensity, are not targeted for poorly adherent patients, and may be best suited for implementation in resource-heavy specialty settings (58, 59).”
BackgroundYatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
Nonadherence With Mood Stabilizers: Prevalence and Predictors
Scott, J., & Pope, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0502 · Cited by 315
Greater Cortical Gray Matter Density in Lithium-Treated Patients with Bipolar Disorder
Bearden, C. E., Thompson, P. M., Dalwani, M., Hayashi, K. M., Lee, A. D., Nicoletti, M., Trakhtenbroit, M., Glahn, D. C., Brambilla, P., Sassi, R. B., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.027 · Cited by 289
Svarstad, B. L., Shireman, T. I., & Sweeney, J. K. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.6.805 · Cited by 281
Treatment adherence with antipsychotic medications in bipolar disorder
Sajatovic, M., Valenstein, M., Blow, F. C., Ganoczy, D., & Ignacio, R. V. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00314.x · Cited by 242 · cited 1×
“Sub-optimal adherence occurs across the full spectrum of classes of pharmacologic agents for BD (5, 6, 17, 18), and the majority of reports suggest that BD medication adherence rates are similar for older compounds such as lithium compared to the newer compounds (19).”
ResultSelf-citationTreatment Adherence With Lithium and Anticonvulsant Medications Among Patients With Bipolar Disorder
Sajatovic, M., Valenstein, M., Blow, F., Ganoczy, D., & Ignacio, R. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.855 · Cited by 172 · cited 1×
“Sub-optimal adherence occurs across the full spectrum of classes of pharmacologic agents for BD (5, 6, 17, 18), and the majority of reports suggest that BD medication adherence rates are similar for older compounds such as lithium compared to the newer compounds (19).”
ResultSelf-citationEnhancing medication adherence in patients with bipolar disorder
Berk, L., Hallam, K. T., Colom, F., Vieta, E., Hasty, M., Macneil, C., & Berk, M. (2010) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1081 · Cited by 149
Cited by
Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s124658 · Cited by 333
“15 Although people with SMI often receive various psycho-tropic medications, antipsychotic drugs are a common therapeutic strategy in a number of chronic psychiatric conditions, including schizophrenia, schizoaffective disorder, and bipolar disorder, and are used as adjunctive treatment to…”
Self-citationDeterminants of adherence to treatment in bipolar disorder: A comprehensive review
Leclerc, E., Mansur, R. B., & Brietzke, E. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.036 · Cited by 171
“Direct measures of medication adherence encountered were pills count (Gonzalez-Pinto et al., 2010; Sajatovic et al., 2012) or blood sampling to evaluate the plasma levels of medications, such as lithium, valproate or carbamazepine (Gonzalez-Pinto et al.”
BackgroundMedication nonadherence and psychiatry
Chapman, S. C. E., & Horne, R. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283642da4 · Cited by 142
Behavioral Interventions to Reduce Cardiovascular Risk Among People with Severe Mental Disorder
Baker, A. L., Forbes, E., Pohlman, S., & McCarter, K. (2022) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072720-012042 · Cited by 9
Metadata
- Authors
- Sajatovic, M., Levin, J., Tatsuoka, C., Micula‐Gondek, W., Fuentes‐Casiano, E., Bialko, C. S., & Cassidy, K. A.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2012-05
- Volume
- 14
- Issue
- 3
- Pages
- 291-300
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W1907241721
- Cited by
- 38
- References
- 10
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Six‐month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. https://app.cochat.ai/papers/10.1111/j.1399-5618.2012.01010.x
- The paper
- Sajatovic, M., Levin, J., Tatsuoka, C., Micula‐Gondek, W., Fuentes‐Casiano, E., Bialko, C. S., & Cassidy, K. A. (2012). Six‐month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2012.01010.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.